SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Zheng JW, Meng SQ, Liu WY, Chang XW, Shi J. Sichuan Da Xue Xue Bao Yi Xue Ban 2023; 54(2): 231-239.

Vernacular Title

镇静催眠药的合理使用与滥用

Copyright

(Copyright © 2023, Sichuan da xue xue bao (yi xue ban) bian ji bu)

DOI

10.12182/20230260302

PMID

36949678

Abstract

The incidence of insomnia has been increasing in recent years. In addition, due to the impact of the COVID-19 pandemic, more and more people are experiencing a variety of insomniac problems, including having difficulty in sleep initation, waking up too early, and short sleep duration. Chronic insomnia may seriously affect patients' life and work, increase their risks of developing physical and mental illnesses, and cause crushing social and economic burdens. Sedative-hypnotics, including benzodiazepine agonists, melatonin receptor agonists, orexin receptor antagonists, and antidepressants with hypnotic effects, are widely used to treat most patients suffering from insomnia. However, there is the phenomenon of the non-medical use and abuse of sedative-hypnotic drugs, especially benzodiazepine receptor agonists. The abuse of sedative-hypnotic drugs may lead to mental and physical dependence, cognitive impairment, depression and anxiety, as well as an increased risks of falls and death. Therefore, drug regulatory authorities in China and other countries have issued relevant policies to reinforce regulation. Herein, we reviewed the prevalent use and safety of sedative-hypnotic drugs and proposed suggestions concerning their appropriate use. Both the efficacy and safety of sedative-hypnotic drugs should be carefully considered so that patients suffering from insomnia receive thorough and prompt treatment and the problem of potential abuse of sedative-hypnotic drugs is assessed in an objective and scientific manner. We also hope to provide references for the standardized clinical use of insomnia drugs.

===

近年来,失眠的发生率日益升高,同时由于疫情的影响,越来越多的人出现了入睡困难、早醒、睡眠时间短等多种失眠问题。长期失眠会严重影响个体的工作和生活,增加罹患躯体以及精神疾病的风险,造成极大的经济和社会负担。镇静催眠药是大多数失眠患者较为常用的治疗手段,主要包括苯二氮䓬类受体激动剂、褪黑素受体激动剂、促食欲素受体拮抗剂和对睡眠具有调节作用的抗抑郁药等。然而,目前存在镇静催眠药非医疗使用和滥用的现象,主要是苯二氮䓬类受体激动剂。这种药物滥用会导致精神和躯体依赖、认知障碍、抑郁焦虑、跌倒风险和死亡风险升高等,因此国内外药品监督管理部门相继出台了有关政策以加强监管。本文对镇静催眠药的使用现状和安全性进行了综述,并提出了合理使用的思考,临床上应辩证地看待镇静催眠药的有效性和安全性,在充分、及时地解决患者失眠问题的同时,也客观、科学地评估其潜在滥用问题,以期为临床失眠药物的规范使用提供参考。

关键词: 失眠 / 镇静催眠药 / 滥用 / 成瘾性 / 安全性 / 合理使用


Language: zh

Keywords

Humans; Safety; Pandemics; Sleep; Abuse; Insomnia; *COVID-19; *Sleep Initiation and Maintenance Disorders/drug therapy; Addictiveness; Appropriate use; Hypnotics and Sedatives/adverse effects; Sedative-hypnotic drugs

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print